Brexit through the lens of British history
science wire
« BACK
Social Sciences - Health - 16:32
Pharmacology - Health - 16:02 
Researchers aim to use gene therapy to treat hearing deafness
Professor Schambach was awarded approximately two million euros from the European Union for his "iHEAR" project / New gene therapies shall protect children and adults from hearing loss High accolades
Health - 11:05 
Microneedle technology gets green light
Innovators at Cardiff Medicentre have pioneered microneedle technology that could end certain types of injections. Picofluidics Ltd - based at Cardiff University's medtech incubator - has completed rigorous proof of concept tests. Working with scientists from Coventry University and backed by funding from Innovate UK, Picofluidics is preparing to go to market.
Health - 10:08
Health - 22.03.2019
Health - Environment - 22.03.2019 
Female radiation oncologists submit fewer charges to Medicare, collect less revenue
A new study by UCLA researchers has found that female radiation oncologists submit fewer charges to Medicare, are reimbursed less per charge submitted and receive lower Medicare payments overall in comparison to male radiation oncologists.
Health - Pharmacology - 22.03.2019
Health - 22.03.2019
Environment - Health - 22.03.2019 
The effects of climate change on water shortages
In Jordan, one of the most water-poor nations, predictions of future droughts depend on the scale of climate change. Without reducing greenhouse gases the future looks dry, but researchers offer some hope. If global temperatures continue to rise, rainfall will increasingly become a beast of extremes: long dry spells here, dangerous floods there - and in some places, intense water shortages.
Health - Life Sciences - 21.03.2019
Health - Pharmacology - 21.03.2019
Innovation / Technology - Health - 21.03.2019
Health - 21.03.2019
Health - 21.03.2019
Health - 20.03.2019
Astronomy / Space Science - Health - 20.03.2019
Health - 20.03.2019
Health - Pharmacology - 20.03.2019
Health - Careers / Employment - 20.03.2019
Life Sciences - Health - 20.03.2019
Health - Life Sciences - 19.03.2019
Health - Life Sciences - 19.03.2019
Health - 19.03.2019
Pharmacology - Health - 19.03.2019
Health - 19.03.2019
Health - 18.03.2019
Business / Economics - Health - 18.03.2019
Computer Science / Telecom - Health - 18.03.2019 
Stanford University launches the Institute for Human-Centered Artificial Intelligence
Stanford University is launching a new institute committed to studying, guiding and developing human-centered artificial intelligence technologies and applications.
Health - 17.03.2019
Life Sciences - Health - 15.03.2019
Health - Business / Economics - 15.03.2019
Health - 15.03.2019
Health - Pharmacology - 15.03.2019 
Researchers offered ’quick and easy’ grants to get medical innovations started
A scheme is offering grants to help researchers test ideas for translating their research into new drugs, diagnostics or medical devices.
Health - Mathematics - 15.03.2019 
Biological blockbusters and viral bloodletting: News from the College
Here's a batch of fresh news and announcements from across Imperial. From the first footage of lung cells forming, to a study of the viral impacts of self-flagellation, here is some quick-read news from across the College. Biological blockbuster A new method for imaging slices of lung tissue may have scientists reaching for the popcorn.
Pharmacology - Health - 15.03.2019
Life Sciences - Health - 15.03.2019 
With single gene insertion, blind mice regain sight
It was surprisingly simple. University of California, Berkeley, scientists inserted a gene for a green-light receptor into the eyes of blind mice and, a month later, they were navigating around obstacles as easily as mice with no vision problems.
Environment - Health - 15.03.2019 
The climate of health
The damage we do to the world is eventually visited upon us in the form of hunger, thirst, physical disease, mental illness and other health issues. Here, we explore those consequences and how we can lessen their severity through global emissions reductions. We teach our children to treat others as they want to be treated, but what about the world around them? As the dominant force driving ecological change, the damage we do to natural life-support systems is eventually visited upon us, perhaps most dramatically in our health.
Health - Environment - 15.03.2019 
The effect of climate change on disease
As the globe warms, mosquitoes will roam beyond their current habitats, shifting the burden of diseases like malaria, dengue fever, chikungunya and West Nile virus.
Health - Pharmacology - 14.03.2019
Health - Administration - 14.03.2019
Health - Life Sciences - 14.03.2019
Health - 14.03.2019
Health - Event - 14.03.2019
Pharmacology - Health - 14.03.2019
Health - Pharmacology - 13.03.2019 
Reducing the burden of tuberculosis treatment
Drug delivery system would allow patients to switch from daily to monthly doses. One-third of the world's population is infected with TB, and more than 1 million people die from the disease every year.
Health - Life Sciences - 13.03.2019
Health - 13.03.2019 
Cancer Research Award goes to two TUM scientists - TUM
Prof. Roland Rad and Prof. Dieter Saur of the Technical University of Munich (TUM) were honored yesterday with the German Cancer Award in the experimental research category.
Health - Pharmacology - 12.03.2019
Health - Environment - 12.03.2019
Health
Results 1 - 50 of 17903.
Change conversation to strengthen gun violence prevention, YSPH dean says
Advocating for stronger gun safety policies is one way to broaden political and community support to reduce gun violence in the United States, Yale School of Public Health Dean Sten H. Vermund said at a public forum Sunday.
Advocating for stronger gun safety policies is one way to broaden political and community support to reduce gun violence in the United States, Yale School of Public Health Dean Sten H. Vermund said at a public forum Sunday.
Professor Schambach was awarded approximately two million euros from the European Union for his "iHEAR" project / New gene therapies shall protect children and adults from hearing loss High accolades
Innovators at Cardiff Medicentre have pioneered microneedle technology that could end certain types of injections. Picofluidics Ltd - based at Cardiff University's medtech incubator - has completed rigorous proof of concept tests. Working with scientists from Coventry University and backed by funding from Innovate UK, Picofluidics is preparing to go to market.
Why I chose global health
The words of Luke Davis' high school teacher still resonate with him as he continues to take on new challenges in diagnosing tuberculosis (TB).
The words of Luke Davis' high school teacher still resonate with him as he continues to take on new challenges in diagnosing tuberculosis (TB).
A new study by UCLA researchers has found that female radiation oncologists submit fewer charges to Medicare, are reimbursed less per charge submitted and receive lower Medicare payments overall in comparison to male radiation oncologists.
Bringing a new generation of drugs to patients
Cardiff University is stepping up the development of new drugs for mental health and central nervous system conditions, with the launch of the Medicines Discovery Institute. Focusing on areas of unmet clinical need, the new institute will develop novel medications to improve the lives of people across the world.
Cardiff University is stepping up the development of new drugs for mental health and central nervous system conditions, with the launch of the Medicines Discovery Institute. Focusing on areas of unmet clinical need, the new institute will develop novel medications to improve the lives of people across the world.
Experts gather to boost detection of deadly melanoma
Experts are gathering in Brisbane today to establish a road map for reducing melanoma deaths in Australia.
Experts are gathering in Brisbane today to establish a road map for reducing melanoma deaths in Australia.
In Jordan, one of the most water-poor nations, predictions of future droughts depend on the scale of climate change. Without reducing greenhouse gases the future looks dry, but researchers offer some hope. If global temperatures continue to rise, rainfall will increasingly become a beast of extremes: long dry spells here, dangerous floods there - and in some places, intense water shortages.
Researchers awarded $40 million to study opioid addiction treatments
Yale School of Medicine faculty have been awarded $40 million in grants to study medication treatment for veterans with opioid addiction.
Yale School of Medicine faculty have been awarded $40 million in grants to study medication treatment for veterans with opioid addiction.
Boost for University plans for major innovation investment in Govan
The University of Glasgow's plans for an expansion of innovation activities in Govan received a significant boost today (Thursday, 21 March) with two projects through to the final stage of a major UK-wide funding stream.
The University of Glasgow's plans for an expansion of innovation activities in Govan received a significant boost today (Thursday, 21 March) with two projects through to the final stage of a major UK-wide funding stream.
Lecture to explore the hunt for other worlds, life on other planets
The number of confirmed planets beyond our solar system, or exoplanets, now nears 4,000. Citizen scientists have joined the search and recently helped discover an exoplanet in the "habitable zone," the range of distances from a star where liquid water may exist on a planet's surface.
The number of confirmed planets beyond our solar system, or exoplanets, now nears 4,000. Citizen scientists have joined the search and recently helped discover an exoplanet in the "habitable zone," the range of distances from a star where liquid water may exist on a planet's surface.
Ground breaking pancreatic cancer trial reaches patient milestone
A ground breaking pancreatic cancer trial, which aims to match patients with more targeted and effective treatment for their tumours, has successfully recruited its 100th patient.
A ground breaking pancreatic cancer trial, which aims to match patients with more targeted and effective treatment for their tumours, has successfully recruited its 100th patient.
Funding secured for fourth wave of the internationally-renowned NATSAL study
The National Survey of Sexual Attitudes and Lifestyles begins its fourth study on sexual health and well-being in Britain, led by researchers from UCL in collaboration with the London School of Hygiene & Tropical Medicine, the University of Glasgow and NatCen Social Research. The National Surveys of Sexual Attitudes and Lifestyles (Natsal) are regarded as the world's largest, most detailed studies of sexual behaviour.
The National Survey of Sexual Attitudes and Lifestyles begins its fourth study on sexual health and well-being in Britain, led by researchers from UCL in collaboration with the London School of Hygiene & Tropical Medicine, the University of Glasgow and NatCen Social Research. The National Surveys of Sexual Attitudes and Lifestyles (Natsal) are regarded as the world's largest, most detailed studies of sexual behaviour.
FDA approves Roche’s Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer
Tecentriq in combination with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy approved for the initial treatment of extensive-stage small cell lung cancer (ES-SCLC
Tecentriq in combination with chemotherapy (carboplatin and etoposide) is the first and only cancer immunotherapy approved for the initial treatment of extensive-stage small cell lung cancer (ES-SCLC
Researcher urges food industry to reduce salt in food
The food industry must do more to lower the amount of salt in their products in order to tackle high blood pressure, says an Imperial expert.
The food industry must do more to lower the amount of salt in their products in order to tackle high blood pressure, says an Imperial expert.
Stanford University is launching a new institute committed to studying, guiding and developing human-centered artificial intelligence technologies and applications.
Why you need to get some shut-eye (and how to do it)
We all know sleep is important for focus, but did you know it could also be the key to keeping your brain healthy as you age? Our new research centre is at the forefront of these discoveries.
We all know sleep is important for focus, but did you know it could also be the key to keeping your brain healthy as you age? Our new research centre is at the forefront of these discoveries.
SOM Insights: Fiona Scott Morton testifies to Congress on healthcare
Prof. Scott Morton called a private healthcare system without competitive pressure "the worst of both worlds" in terms of costs.
Prof. Scott Morton called a private healthcare system without competitive pressure "the worst of both worlds" in terms of costs.
Since 1990s, heart attacks have become less deadly, frequent for Americans
Heart attack prevention and outcomes have dramatically improved for American adults in the past two decades, according to a Yale study in JAMA Network Open.
Heart attack prevention and outcomes have dramatically improved for American adults in the past two decades, according to a Yale study in JAMA Network Open.
A scheme is offering grants to help researchers test ideas for translating their research into new drugs, diagnostics or medical devices.
Here's a batch of fresh news and announcements from across Imperial. From the first footage of lung cells forming, to a study of the viral impacts of self-flagellation, here is some quick-read news from across the College. Biological blockbuster A new method for imaging slices of lung tissue may have scientists reaching for the popcorn.
European Commission approves Roche’s MabThera (rituximab) for a rare autoimmune disease
MabThera is the first biologic treatment approved for moderate to severe cases of the rare autoimmune disease pemphigus vulgaris (PV), and the first major advancement in the treatment of the disease
MabThera is the first biologic treatment approved for moderate to severe cases of the rare autoimmune disease pemphigus vulgaris (PV), and the first major advancement in the treatment of the disease
It was surprisingly simple. University of California, Berkeley, scientists inserted a gene for a green-light receptor into the eyes of blind mice and, a month later, they were navigating around obstacles as easily as mice with no vision problems.
The damage we do to the world is eventually visited upon us in the form of hunger, thirst, physical disease, mental illness and other health issues. Here, we explore those consequences and how we can lessen their severity through global emissions reductions. We teach our children to treat others as they want to be treated, but what about the world around them? As the dominant force driving ecological change, the damage we do to natural life-support systems is eventually visited upon us, perhaps most dramatically in our health.
As the globe warms, mosquitoes will roam beyond their current habitats, shifting the burden of diseases like malaria, dengue fever, chikungunya and West Nile virus.
Novartis joins the Global Chagas Disease Coalition and also announces first multinational, prospective, randomized study in people with chronic Chagas cardiomyopathy
Study is planned to assess efficacy and safety of Entresto (sacubitril / valsartan) vs enalapril in 900 patients with chronic Chagas cardiomyopathy; recruitment is planned to commence within 2019 C
Study is planned to assess efficacy and safety of Entresto (sacubitril / valsartan) vs enalapril in 900 patients with chronic Chagas cardiomyopathy; recruitment is planned to commence within 2019 C
Gut bacteria neutralizes disease-carrying tsetse flies
Yale School of Public Health Research Scientist Brian Weiss, Ph.D.
Yale School of Public Health Research Scientist Brian Weiss, Ph.D.
European Commission approves Roche’s Hemlibra for people with severe haemophilia A without factor VIII inhibitors
First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis, in a prospective intra-patient comparison Only prophylactic medicine that can be given subcutaneously
First medicine to significantly reduce treated bleeds compared to prior factor VIII prophylaxis, in a prospective intra-patient comparison Only prophylactic medicine that can be given subcutaneously
Drug delivery system would allow patients to switch from daily to monthly doses. One-third of the world's population is infected with TB, and more than 1 million people die from the disease every year.
Prof. Roland Rad and Prof. Dieter Saur of the Technical University of Munich (TUM) were honored yesterday with the German Cancer Award in the experimental research category.
Evidence-based web tool aims to better inform and refine need for treatment in early prostate cancer
A new tool to predict an individual's prognosis following a prostate cancer diagnosis could help prevent unnecessary treatment and related side effects, say researchers at the University of Cambridge. We believe this tool could significantly reduce the number of unnecessary - and potentially harmful - treatments that patients receive and save the NHS millions every year Vincent Gnanapragasam The tool, PREDICT Prostate, launches today to coincide with publication in the journal PLOS Medicine of the research that underpins it.
A new tool to predict an individual's prognosis following a prostate cancer diagnosis could help prevent unnecessary treatment and related side effects, say researchers at the University of Cambridge. We believe this tool could significantly reduce the number of unnecessary - and potentially harmful - treatments that patients receive and save the NHS millions every year Vincent Gnanapragasam The tool, PREDICT Prostate, launches today to coincide with publication in the journal PLOS Medicine of the research that underpins it.
A better brick
A worker on the outskirts of Dhaka, Bangladesh, carries newly fired bricks to transport trucks that will take them to market.
A worker on the outskirts of Dhaka, Bangladesh, carries newly fired bricks to transport trucks that will take them to market.